Miriam Kidron, Chief Scientific Officer at ORAMED PHARMACEUTICALS INC. (ORMP), sold 200,000 shares at $2.01 ($402K) on 2023-03-14, disclosed to the SEC on 2023-03-15.
Open-market sale of $402k ORMP by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.01 | 100,000 | $201K | 50.0% |
| 2 | $2.01 | 100,000 | $201K | 50.0% |
| Total | $2.01 avg | 200,000 | $402K | 100% |
| Filing → |
| ORMP | SELL | 2015-12-31 | $445K | — | Filing → |
| ORMP | SELL | 2014-09-12 | $267K | — | Filing → |
| ORMP | SELL | 2014-04-03 | $1.7M | — | Filing → |